Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
13841
-
13842
-
13843
-
13844
-
13845
-
13846
-
13847
Minimal dataset.
Published 2025“…The initial search was performed on January 28, 2024, and there were no restrictions on the time frame for the search. Ultimately, we employed a two-stage random effects model using the “drmeta” package in Stata software to perform this dose-response meta-analysis.…”
-
13848
-
13849
-
13850
PCAIs inhibit NCI-H23 cell line viability.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
13851
PCAIs disrupt actin filaments in NCI-H23 cells.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
13852
PCAIs suppress 3D NCI-H23 cell invasion.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
13853
PCAIs suppress NCI-H23 cancer cell migration.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
13854
PCAIs induce apoptosis in NCI-H23 cells.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
13855
Hemodynamic parameters.
Published 2024“…Annular height marginally decreased with AF from 5.8±1.9mm to 5.7±2.0mm; <i>p</i> = 0.039.…”
-
13856
Tricuspid annular dimensions.
Published 2024“…Annular height marginally decreased with AF from 5.8±1.9mm to 5.7±2.0mm; <i>p</i> = 0.039.…”
-
13857
Regional tricuspid annular perimeter.
Published 2024“…Annular height marginally decreased with AF from 5.8±1.9mm to 5.7±2.0mm; <i>p</i> = 0.039.…”
-
13858
-
13859
-
13860